Clinical trials: Blood Coagulation Disorders

Severe Hemophilia A

Efficacy and Safety Study of Human-cl rhFVIII in PTPs With Severe Hemophilia A

• Completed
• Age: 12 years and older
• Phase 3
• Results posted

This study will determine the efficacy of human-cl rhFVIII in previously treated patients with severe hemophilia A during prophylactic treatment, treatment of bleeding episodes and in surgical prophylaxis.

Trial name

NCT01125813

Testing

recombinant Factor VIII

Where

11 sites in Austria, Bulgaria and 2 more

Volunteers

32 people

Sponsor

Octapharma